Instituto COI de Pesquisa, Educação e Gestão

Rio de Janeiro 22793-080

0 studies enrolling now · 3 studies all time

What they study most

HER-2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer, Metastatic Renal Cell Carcinoma, Multiple Myeloma, Renal Cell Carcinoma

Studies at this site

• A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma — Running, not enrolling
• A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer — Completed
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early